Stay updated with breaking news from Brainstorm Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com initiated coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a report issued on Sunday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, Maxim Group downgraded shares of Brainstorm Cell Therapeutics from a buy rating to a hold rating in a research report on Thursday, September […]
NEW YORK, Jan. 2, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Brainstorm Cell Therapeutics Inc. of a class action securities lawsuit. ...
INVESTOR ALERT: Levi & Korsinsky Notifies Shareholders of Brainstorm ...
FINAL BCLI DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Brainstorm ...
FINAL BCLI DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Brainstorm ...